Exelixis Inc (EXEL)
21.86
-0.26
(-1.18%)
USD |
NASDAQ |
May 03, 14:49
Exelixis Free Cash Flow: 185.10M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 185.10M |
| December 31, 2023 | 170.36M |
| September 30, 2023 | 134.15M |
| June 30, 2023 | 212.68M |
| March 31, 2023 | 117.93M |
| December 31, 2022 | 224.16M |
| September 30, 2022 | 343.42M |
| June 30, 2022 | 310.20M |
| March 31, 2022 | 452.70M |
| December 31, 2021 | 336.58M |
| September 30, 2021 | 275.09M |
| June 30, 2021 | 218.09M |
| March 31, 2021 | 151.51M |
| December 31, 2020 | 178.64M |
| September 30, 2020 | 310.40M |
| June 30, 2020 | 372.14M |
| March 31, 2020 | 407.95M |
| December 31, 2019 | 514.12M |
| September 30, 2019 | 465.06M |
| June 30, 2019 | 541.14M |
| March 31, 2019 | 472.85M |
| December 31, 2018 | 382.42M |
| September 30, 2018 | 316.38M |
| June 30, 2018 | 203.46M |
| March 31, 2018 | 145.28M |
| Date | Value |
|---|---|
| December 31, 2017 | 144.47M |
| September 30, 2017 | 193.33M |
| June 30, 2017 | 150.80M |
| March 31, 2017 | 120.63M |
| December 31, 2016 | 208.70M |
| September 30, 2016 | 88.95M |
| June 30, 2016 | 60.51M |
| March 31, 2016 | 59.75M |
| December 31, 2015 | -141.50M |
| September 30, 2015 | -156.26M |
| June 30, 2015 | -180.12M |
| March 31, 2015 | -208.53M |
| December 31, 2014 | -235.88M |
| September 30, 2014 | -233.30M |
| June 30, 2014 | -232.86M |
| March 31, 2014 | -218.27M |
| December 31, 2013 | -200.94M |
| September 30, 2013 | -193.45M |
| June 30, 2013 | -170.85M |
| March 31, 2013 | -165.97M |
| December 31, 2012 | -125.86M |
| September 30, 2012 | -115.39M |
| June 30, 2012 | -123.73M |
| March 31, 2012 | -131.58M |
| December 31, 2011 | -160.22M |
Free Cash Flow Range, Past 5 Years
117.93M
Minimum
Mar 2023
541.14M
Maximum
Jun 2019
296.07M
Average
292.65M
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals Inc | 3.668B |
| Johnson & Johnson | 18.23B |
| Merck & Co Inc | 9.143B |
| Pfizer Inc | 4.793B |
| Legend Biotech Corp | -416.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 68.82M |
| Cash from Investing (Quarterly) | 111.79M |
| Cash from Financing (Quarterly) | -184.05M |
| Free Cash Flow Per Share (Quarterly) | 0.1657 |
| Free Cash Flow to Equity (Quarterly) | 50.63M |
| Free Cash Flow to Firm (Quarterly) | 50.63M |
| Free Cash Flow Yield | 2.68% |